RaQualia Pharma, Inc.

77
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3967150008
JPY
789.00
-6 (-0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
3,979.00
3,107.00
1,901.00
2,918.00
2,776.00
1,107.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3,979.00
3,107.00
1,901.00
2,918.00
2,776.00
1,107.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
61.00
184.00
6.00
5.00
1.00
0.00
General and Administration Expenses
891.00
780.00
613.00
565.00
614.00
517.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,496.00
3,320.00
2,238.00
2,051.00
2,068.00
1,593.00
Operating Profit (PBDIT) excl Other Income
483.00
-213.00
-337.00
866.00
707.00
-486.00
Other Income
-10.00
63.00
71.00
55.00
184.00
-39.00
Operating Profit (PBDIT)
960.00
251.00
-90.00
1,069.00
1,033.00
-401.00
Interest
61.00
184.00
6.00
5.00
1.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
488.00
401.00
175.00
147.00
141.00
124.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
437.00
-357.00
-294.00
851.00
880.00
-527.00
Provision for Tax
164.00
137.00
29.00
127.00
124.00
79.00
Profit After Tax
273.00
-495.00
-323.00
723.00
755.00
-606.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
11.36
-22.87
-14.98
34.47
36.04
-28.97
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 326.69% vs 36.75% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -66.84% vs 2,655.79% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 155.17% vs -52.95% in Dec 2024

Compare Profit and Loss Results of RaQualia Pharma, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
3,979.00
0.00
3,979.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,979.00
0.00
3,979.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
61.00
0.00
61.00
0%
General and Administration Expenses
891.00
193.00
698.00
361.66%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,496.00
1,013.00
2,483.00
245.11%
Operating Profit (PBDIT) excl Other Income
483.00
-1,013.00
1,496.00
147.68%
Other Income
-10.00
-47.00
37.00
78.72%
Operating Profit (PBDIT)
960.00
-1,156.00
2,116.00
183.04%
Interest
61.00
0.00
61.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
488.00
0.00
488.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
437.00
-1,156.00
1,593.00
137.80%
Provision for Tax
164.00
1.00
163.00
16,300.00%
Profit After Tax
273.00
-1,157.00
1,430.00
123.60%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
11.3552
-61.1407
72.50
118.57%
Profit And Loss - Net Sales
Net Sales 3,979.96 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 483.72 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 326.69% vs 36.75% in Dec 2024

Profit And Loss - Interest
Interest 61.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -66.84% vs 2,655.79% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 273.12 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 155.17% vs -52.95% in Dec 2024